Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24428468 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450;   Drug: ABT-333;   Drug: ABT-267;   Drug: Ribavirin;   Drug: Ritonavir

Indicates status has not been verified in more than two years